To determine if BRCA1/2 may facilitate HR-dependent lesion bypass of APOBEC-induced DNA damage in breast cancer, we assessed SBS13 mutations for replicative asymmetry associated with deamination of the lagging strand template in the absence of BRCA1 or BRCA2 (Fig. 6C). This evidence concerns the gene BRCA2 and breast carcinoma.